JenniferJWhelerMD

Clinical Trials

• Valproic Acid and Bevacizumab in Patients With Advanced Cancer Start of enrollment: 2007 Jun 01

  Completed

  Phase 1

• MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors Start of enrollment: 2007 Nov 01

  Suspended

  Phase 1

• Study of Erlotinib in Combination With Dasatinib Start of enrollment: 2009 Apr 01

  Completed

  Phase 1

• Erlotinib in Combination With Cetuximab Start of enrollment: 2009 Apr 01

  Completed

  Phase 1

• Study of Erlotinib in Combination With Bortezomib Start of enrollment: 2009 Apr 01

  Completed

  Phase 1

• An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status Start of enrollment: 2009 Apr 01

  Completed

  Phase 1

• TTP607 in Refractory Solid Malignancies Start of enrollment: 2010 Mar 01

  Withdrawn

  Phase 1

• Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance Start of enrollment: 2010 Sep 07

  Completed

  Phase 1

• A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours Start of enrollment: 2011 Jan 01

  Completed

  Phase 1

• Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients Start of enrollment: 2011 Oct 07

  Completed

  Phase 1

• Erlotinib in Combination With Pralatrexate in Advanced Malignancies Start of enrollment: 2012 Mar 01

  Completed

  Phase 1

• BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors Start of enrollment: 2013 Oct 01

  Completed

  Phase 1

• Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients Start of enrollment: 2014 Jul 17

  Completed

  Phase 1

• Join now to see all